SUVRETTA CAPITAL MANAGEMENT, LLC

Position in ERAS — Erasca, Inc.

CIK 1569064 New York, NY

Position in ERAS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$55,577,766

+$1,630,312 QoQ

Shares Held

3,434,967

-76.3% QoQ

Ownership

1.10%

of shares outstanding

% of Portfolio

1.52%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,459,096,047 across 36 Biotechnology names. ERAS ranks #17 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARQT	Arcutis Biotherapeutics, Inc.	12,327,000	$290,424,120
2	MANE	Veradermics, Inc	4,168,970	$263,270,455
3	PVLA	Palvella Therapeutics, Inc.	1,153,496	$143,783,276
4	APLS	Apellis Pharmaceuticals, Inc.	3,518,471	$141,548,088
5	LEGN	Legend Biotech Corp	7,581,029	$137,140,814
6	BNTC	Benitec Biopharma Inc.	11,548,351	$122,989,938
7	CAPR	Capricor Therapeutics, Inc.	3,818,600	$116,085,440
8	IMTX	Immatics N.V.	11,190,129	$110,110,869

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$55,577,766	3,434,967	0.0%	Shares	Sole	2026-05-12
2026-03-31	$55,577,766	3,434,967	-76.3%	Shares	Sole	2026-05-15
2025-12-31	$53,947,454	14,502,004	0.0%	Shares	Sole	2026-02-17
2025-09-30	$31,614,368	14,502,004	0.0%	Shares	Sole	2025-11-14
2025-06-30	$18,417,545	14,502,004	+17.8%	Shares	Sole	2025-08-14
2025-03-31	$16,871,555	12,315,004	0.0%	Shares	Sole	2025-05-15
2024-12-31	$30,910,660	12,315,004	-10.6%	Shares	Sole	2025-02-14
2024-09-30	$37,586,746	13,768,039	0.0%	Shares	Sole	2024-11-14
2024-06-30	$32,492,572	13,768,039	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.